Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A high-throughput proteomic approach provides distinct signatures for thyroid cancer behavior.

Clinical cancer research : an official journal of the American Association for Cancer Research - 15 Apr 2011

Cheng Sonia, Serra Stefano, Mercado Moises, Ezzat Shereen, Asa Sylvia L

Abstract excerpt

PURPOSE: Well-differentiated thyroid cancer (WDTC) is the most frequent form of endocrine neoplasia. One of the main challenges in the management of this disease is distinguishing low-risk patients who can be treated by surgical resection of the lesion from those with a high likelihood of recurrence who need a more extensive approach, including total thyroidectomy and radioiodine ablation. EXPERIMENTAL DESIGN: A...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Papillary
Share to Cyclin D1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Estrogen Receptor beta

Share to Galectin 3

Share to Keratin-19

Share to Proteome

Share to Thyroidectomy

Share to Tissue Array Analysis

Source

Identifiers

PMID: 21389096
DOI: 10.1158/1078-0432.CCR-10-2837

Genes

BRAF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A high-throughput proteomic approach provides distinct signatures for thyroid cancer behavior.PMID 21389096Read ↗

Distinct molecular subtypes of papillary thyroid carcinoma and gene signature with diagnostic capability.Semantic proximity Read ↗

Leveraging the transcriptome-phenotype relationship to guide clinical management of papillary thyroid cancer.Semantic proximity Read ↗

Integrated genomic characterization of papillary thyroid carcinoma.Semantic proximity Read ↗

Proteogenomic characterization delineates clinically relevant subtypes of advanced differentiated thyroid cancer.Semantic proximity Read ↗

Genomics and Multi-Omics to Guide Clinical Management in Thyroid CancerSemantic proximity Read ↗

Clinical Characteristics and Prognostic Markers of Aggressive Subtypes of Thyroid Cancer: A Retrospective Chart Review StudySemantic proximity Read ↗

High aggressiveness of papillary thyroid cancer: from clinical evidence to regulatory cellular networksSemantic proximity Read ↗

Progress in molecular-based management of differentiated thyroid cancer.Semantic proximity Read ↗

Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers.Semantic proximity Read ↗

Genomic Landscape of poorly Differentiated and Anaplastic Thyroid Carcinoma.Semantic proximity Read ↗

Molecular Profiles of Noninvasive, Minimally Invasive, and Invasive Follicular Patterned Thyroid Neoplasms with Papillary Nuclear Features.Semantic proximity Read ↗

Molecular features of aggressive thyroid cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.